--- title: "U.S. stock market midday update: Tenet Healthcare rises 21.35%, earnings exceed expectations + buyback boosts confidence" type: "News" locale: "en" url: "https://longbridge.com/en/news/293774786.md" description: "Tenet Healthcare rose 21.35%; HCA Holdings rose 3.61%, with a transaction volume of USD 296 million; Universal Health Services rose 5.88%, with a transaction volume of USD 7.777 million; Encompass Health rose 2.95%, with a transaction volume of USD 2.55 million; Ensign Group rose 3.37%, with a market value of USD 10.1 billion" datetime: "2026-07-24T15:17:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293774786.md) - [en](https://longbridge.com/en/news/293774786.md) - [zh-HK](https://longbridge.com/zh-HK/news/293774786.md) --- # U.S. stock market midday update: Tenet Healthcare rises 21.35%, earnings exceed expectations + buyback boosts confidence **U.S. Stock Market Midday Update** Tenet Healthcare rose 21.35%. Based on recent news, 1. On July 24, Tenet Healthcare raised its revenue forecast for 2026 to $21.9 billion to $22.5 billion, exceeding analysts' expectations of $21.98 billion, while also raising its adjusted earnings per share forecast to $20.30 to $21.69, far above analysts' expectations of $17.83. This news drove the stock price up by 15.6%. 2. On July 24, Tenet Healthcare reported second-quarter sales of $5.63 billion, with adjusted earnings per share of $6.12, both exceeding analysts' expectations. This strong performance further boosted market confidence. 3. On July 24, Tenet Healthcare's board approved an additional $2 billion stock repurchase plan, increasing the remaining repurchase authorization to approximately $2.13 billion, enhancing investor confidence in the company's future performance. The healthcare industry is performing strongly overall, with significant policy support. **Stocks with High Trading Volume in the Industry** HCA Holdings rose 3.61%. Based on recent key news: 1. On July 24, HCA Healthcare reported second-quarter results, with revenue and profit both exceeding market expectations. The company's revenue was $20.23 billion, an 8.7% year-over-year increase, and net profit was $1.699 billion, with earnings per share of $7.62, surpassing market expectations. This performance drove the stock price up. 2. On July 24, the company lowered its full-year earnings guidance, primarily due to an approximately $400 million pre-tax profit impact from changes in patient payment structures. Despite the quarterly performance exceeding expectations, investors remain cautious about the ongoing impact of payment structure changes. 3. On July 24, HCA announced a quarterly cash dividend of $0.78 per share, unchanged for three consecutive quarters. The stable dividend policy has enhanced investor confidence. The healthcare industry faces risks from changes in payment structures. Universal Health Services rose 5.88%. Based on recent key news: 1. On July 21, Universal Health Services announced the twelfth amendment to its credit agreement, adding a new incremental delayed draw loan facility of up to $700 million. This move enhances the company's financial flexibility and drove the stock price up. 2. On July 21, Universal Health Services released relevant information through the EDGAR system, further solidifying market confidence in its financial condition and promoting stock price increases. The industry is experiencing capital inflows, and the macroeconomic environment is stable. Encompass Health rose 2.95%. Based on recent news, 1. On July 23, Encompass Health announced an increase in its quarterly common stock dividend by $0.02 to $0.21 per share. This news boosted investor confidence and drove the stock price up On July 24, despite Encompass Health currently having a "Moderate Buy" rating among analysts, top analysts believe there are five stocks more worthy of purchase than Encompass Health. This news had some impact on market sentiment but failed to prevent the stock price from rising. Market sentiment is positive, and trading volume has increased. **Stocks Ranked Among the Top by Market Capitalization in the Industry** Encompass Health rose by 3.37%. Based on recent key news: 1. On July 22, Encompass Health Group director John O. Agwunobi sold 392 shares of common stock at a transaction price of $171.06 per share. This move may raise market attention on insider trading within the company, leading to stock price fluctuations. 2. On July 22, Rosen Law Firm encouraged Encompass Health Group investors to investigate a securities class action lawsuit. This may have increased market concerns about the company's legal risks, affecting the stock price. 3. No other significant news recently. The U.S. market has seen increased volatility recently, which needs attention ### Related Stocks - [THC.US](https://longbridge.com/en/quote/THC.US.md) - [HCA.US](https://longbridge.com/en/quote/HCA.US.md) - [UHS.US](https://longbridge.com/en/quote/UHS.US.md) - [EHC.US](https://longbridge.com/en/quote/EHC.US.md) - [ENSG.US](https://longbridge.com/en/quote/ENSG.US.md) ## Related News & Research - [Arrowstreet Capital Limited Partnership Increases Stock Position in Tenet Healthcare Corporation $THC](https://longbridge.com/en/news/293838073.md) - [Tenet Healthcare (NYSE:THC) Price Target Raised to $280.00](https://longbridge.com/en/news/294063839.md) - [Tenet Healthcare director Christopher S. Lynch sells 3,837 shares for $934,080.48](https://longbridge.com/en/news/294126379.md) - [Tenet Healthcare (THC) Stock Faces Cautious Narratives Despite Strong Q2 EPS And Margin Performance](https://longbridge.com/en/news/293823409.md) - [BUZZ-Tenet Healthcare jumps after lifting annual forecast](https://longbridge.com/en/news/293741662.md)